Reid G, Kumar H, Khan AI, Rautava S, Tobin J, Salminen S: The case in favour of probiotics before, during and after pregnancy: insights from the first 1,500 days. Benef Microbes. 2016: 1-10.
Onderdonk AB, Delaney ML, Fichorova RN: The Human Microbiome during Bacterial Vaginosis. Clin Microbiol Rev. 2016; 29 (2): 223-38.
Faure E, Faure K, Figeac M, Kipnis E, Grandjean T, Dubucquoi S, Villenet C, Grandbastien B, Brabant G, Subtil D, Dessein R: Vaginal Mucosal Homeostatic Response May Determine Pregnancy Outcome in Women With Bacterial Vaginosis: A Pilot Study. Medicine (Baltimore). 2016; 95 (5): e2668.
Mitra A, MacIntyre DA, Lee YS, Smith A, Marchesi JR, Lehne B, Bhatia R, Lyons D, Paraskevaidis E, Li JV, Holmes E, Nicholson JK, Bennett PR, Kyrgiou M: Cervical intraepithelial neoplasia disease progression is associated with increased vaginal microbiome diversity. Sci Rep. 2015; 5: 16865.
Kovachev SM, Vatcheva-Dobrevska RS: Local Probiotic Therapy for Vaginal Candida albicans Infections. Probiotics Antimicrob Proteins. 2015; 7 (1): 38-44.
Green KA, Zarek SM, Catherino WH: Gynecologic health and disease in relation to the microbiome of the female reproductive tract. Fertil Steril. 2015; 104 (6): 1351-7
Witkin SS: The vaginal microbiome, vaginal anti-microbial defence mechanisms and the clinical challenge of reducing infection-related preterm birth. BJOG. 2015; 122 (2): 213-8.
Prince AL, Chu DM, Seferovic MD, Antony KM, Ma J, Aagaard KM: The perinatal microbiome and pregnancy: moving beyond the vaginal microbiome. Cold Spring Harb Perspect Med. 2015; 5 (6)
Pines A: Microbiotica in women. Climacteric. 2015;18 (5): 666-8
Borges S, Silva J, Teixeira P: The role of lactobacilli and probiotics in maintaining vaginal health. Arch Gynecol Obstet. 2014; 289 (3): 479-89
Kovachev SM: Obstetric and gynecological diseases and complications resulting from vaginal dysbacteriosis. Microb Ecol. 2014; 68 (2): 173-84
Vicariotto F, Mogna L, Del Piano M: Effectiveness of the two microorganisms Lactobacillus fermentum LF15 and Lactobacillus plantarum LP01, formulated in slow-release vaginal tablets, in women affected by bacterial vaginosis: a pilot study. J Clin Gastroenterol. 2014; 48 Suppl 1: S106-12
Fredricks DN, Fiedler TL, Marrazzo JM: Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med. 2005; 353 (18): 1899-911
